RAYMOND JAMES & ASSOCIATES - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q2 2018$1,027,000
+5.8%
1,108,0000.0%0.00%0.0%
Q1 2018$971,000
-0.1%
1,108,0000.0%0.00%0.0%
Q4 2017$972,000
-2.7%
1,108,0000.0%0.00%0.0%
Q3 2017$999,000
-15.9%
1,108,0000.0%0.00%
-33.3%
Q2 2017$1,188,000
-0.2%
1,108,0000.0%0.00%0.0%
Q1 2017$1,190,000
-2.8%
1,108,000
-0.9%
0.00%0.0%
Q4 2016$1,224,000
+6.0%
1,118,000
+15.5%
0.00%0.0%
Q3 2016$1,155,000
+6.2%
968,000
+11.5%
0.00%0.0%
Q2 2016$1,088,000
+112.9%
868,000
+120.9%
0.00%
+50.0%
Q1 2016$511,000
-16.8%
393,0000.0%0.00%0.0%
Q4 2015$614,000
+15.2%
393,0000.0%0.00%0.0%
Q3 2015$533,000
-13.9%
393,000
-11.3%
0.00%0.0%
Q2 2015$619,000
-5.6%
443,0000.0%0.00%
-33.3%
Q1 2015$656,000
-1.1%
443,000
-8.7%
0.00%0.0%
Q4 2014$663,000
+1.2%
485,000
-4.9%
0.00%
-25.0%
Q3 2014$655,000
+0.5%
510,0000.0%0.00%0.0%
Q2 2014$652,000
+0.8%
510,0000.0%0.00%0.0%
Q1 2014$647,000
+19.4%
510,0000.0%0.00%0.0%
Q4 2013$542,000
+2.5%
510,0000.0%0.00%
-20.0%
Q3 2013$529,000
-0.9%
510,0000.0%0.01%0.0%
Q2 2013$534,000510,0000.01%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2017
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders